#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Hepatic angiosarcoma Thyroid cancer metastatic Prolymphocytic leukaemia Follicular lymphoma Diffuse large B-cell lymphoma refractory Pituitary-dependent Cushing's syndrome Primary hyperoxaluria High-grade B-cell lymphoma Congenital disorder of glycosylation Focal segmental glomerulosclerosis Fungal infection Peripheral primitive neuroectodermal tumour of soft tissue Myelodysplastic syndrome with excess blasts Congenital leptin deficiency Polymyositis More trials…

    Learn about Rare Diseases

    Mucous membrane pemphigoid – Life with Disease Isodicentric chromosome 15 syndrome – Life with Disease Gastrointestinal stromal tumour – Trials in Disease Angiosarcoma metastatic – Basic Information Pemphigoid – Trials in Disease Wolfram syndrome – Treatment Short-bowel syndrome Hereditary motor and sensory neuropathy Ewing’s sarcoma – Diagnostics Leiomyosarcoma metastatic – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    ALE.P02 Vinorelbine Dexamethasone Acetate Imidapril Hydrochloride F44/10 Pariglasgene Brecaparvovec Ketoprofen Lysine Gentamicin Sulfate Dorocubicel Axicabtagene Ciloleucel Ofloxacin Acenocoumarol Mva-209-Fsp-B2 Xxb750 Remestemcel Transpocart19 Mosunetuzumab Cyclophosphamide Monohydrate Dobutamine Clofutriben More therapies…

    Learn about Your Condition

    Neurotrophic keratopathy Malignant neoplasm of choroid Lymphocyte adoptive therapy Piriformis syndrome Pelizaeus-Merzbacher disease Multifocal motor neuropathy Muscular dystrophy Epiphysiolysis Breast neoplasm Pulmonary tuberculosis Tricuspid valve disease Mucopolysaccharidosis III Metachromatic leukodystrophy Malignant oligodendroglioma Prolymphocytic leukaemia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Renal transplant

  • Study on How Tacrolimus Monohydrate and Mycophenolate Mofetil Affect Gut Bacteria in Patients with Chronic Kidney Disease After Transplant

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Chronic kidney disease
    • Renal transplant
    Investigated Drugs:
    • Tacrolimus Monohydrate
    • Mycophenolate Mofetil
    Belgium

  • Study of Mycophenolate and Tacrolimus Effects on Gut Microbiome in Kidney Transplant Patients

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Renal transplant
    Investigated Drugs:
    • Mycophenolate Mofetil
    • Tacrolimus
    Norway

  • Study of Dapagliflozin to Preserve Function in Transplanted Kidneys

    Recruiting

    3 1 1
    Investigated Diseases:
    • Renal transplant
    Investigated Drugs:
    • Dapagliflozin
    Norway

  • Study on 7-Day vs. 14-Day Antibiotic Treatment for Kidney Infection in Transplant Patients Using Bromhexine Hydrochloride, Trimethoprim, and Fluoroquinolones

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Pyelonephritis
    • Pyelonephritis acute
    • Renal transplant
    Investigated Drugs:
    • Tolu Balsam
    • Bromhexine Hydrochloride
    • Sulfamethoxazole
    France

  • Study on Rituximab for Preventing Epstein-Barr Virus Infection and Lymphoproliferative Disorders in EBV-Negative Kidney Transplant Patients

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Epstein-Barr virus infection
    • Renal transplant
    Investigated Drugs:
    • Rituximab
    France

  • Study on Human Normal Immunoglobulin to Prevent BKV Infection in Kidney Transplant Patients with Low Antibody Levels

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Renal transplant
    Investigated Drugs:
    • Human Normal Immunoglobulin
    France
Previous Page
1 2 3 4 5 … 9
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!